Reflect Scientific Awarded Patent for COVID Vaccine Capable- Self Powered, Low Temperature Controlled Bulk Shipping System
- Dow, S&P post worst week in months after hawkish Fed spooks investors
- Fed-fueled dollar rises as bears make for exits
- Adobe (ADBE) Edges Higher After Topping Q2 Estimates, Analysts Raise PT on 'Impressive' Performance
- Fed Statement Very Bullish for Tech Stocks, Focus on Cloud and Cyber Stocks - Wedbush
- You Fight Real Physical Inflation With Rate Hikes, Not Talk of Rate Hikes; Buy the Dip in Commodities, Gold Underpriced - Goldman Sachs
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
OREM, Utah, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces a recently awarded patent for a cryogenic modular shipping unit that can reliably and uniformly maintain its payload at temperatures as low as -90 degrees Celsius, making it an ideal system for cold chain management of biologics like COVID 19 vaccines. The cryogenic system provides the customer with a capability of short or long duration bulk shipping and may also be used for long term storage.
The commercially available Cryometrix S-90 shipping system eliminates managing loads of dry ice, waiting hours for the temperature to saturate the shipping container, and having little to no control over the products’ temperature during shipping. The Cryometrix S-90 bundles our innovative upright liquid nitrogen freezer technology with an onboard liquid nitrogen tank and power supply. You can ship up to 33.5 cubic feet of product (or 70,000 vials) at a controlled temperature between +20°C down to -90°C with a uniformity of ± 3°C.
The S-90 features state-of-the-art temperature and data logging that can be easily accessed through the touch screen or downloaded to a computer. Security issues are mitigated with 3 security levels and up to 30 users. Who can open the freezer is easily controlled along with, who can change the temperature set-point, and who can change the settings. Each Cryometrix shipping system is customizable to meet individual shipping needs. Whether it is going to be used for cross country shipping at -90°C or for short trips across a campus, the S-90 will give you ease and peace of mind in transporting valuable vaccines and biologics.
Cryometrix offers a comprehensive selection of cryogenic storage freezers, ultra low-temperature freezers, blast freezers, blood bank freezers, shipping containers, and transportation refrigeration units. Cryometrix freezing, cooling, and refrigeration systems use our revolutionary patented liquid nitrogen technology. Why use liquid nitrogen- because you eliminate the use of unreliable compressors, no Chlorofluorocarbons (CFC's), low electrical energy usage and significantly reduced maintenance.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, the company develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low-temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. Visit www.reflectscientific.com for more information. See us on Twitter #ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a0e94cc5-8721-44ce-80e1-bcc9c8ce9bb3
Contact Thomas Tait 801-226-4100 firstname.lastname@example.org
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Australian Genomic Sequencing Leader Accelerates Research with Cloudian
- National Loans Compares Secured and Unsecured Loans
- World Mourns Auschwitz Survivor and Innovator in Holocaust Education
Create E-mail Alert Related CategoriesGlobe Newswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!